関連する実験動画
Updated: Jun 19, 2026

10:36
Probiotic Studies in Neonatal Mice Using Gavage
Published on: January 27, 2019
新生児性セプシスの抗生物質治療:変化する傾向と将来の方向性
Pg Genevieve Fung1, E Kam Lun Hon1,2, Kc Alexander Leung3
1Department of Paediatrics, Prince of Wales Hospital, The Chinese University of Hong Kong, NT, Hong Kong.
Drugs in context
|February 20, 2026
まとめ
新生児性セプシスは,迅速な診断と抗生物質治療を必要とする重大な状態です. 効果的な管理には,病原体の特定,合理的な抗生物質の使用,および新生児集中治療室 (NICU) の耐性に対抗するための抗生物質管理が含まれます.
科学分野:
- 新生児医学 新生児医学
- 感染症 感染症は感染症です.
- 薬理学 薬理学とは
背景:
- 新生児のセプシスは,新生児集中治療室 (NICU) の早産児にとって重大な脅威となり,高い罹病率と死亡率につながります.
- このレビューは,新生児性セプシスの原因,診断,および抗生物質治療戦略を扱っており,抗生物質管理を強調しています.
研究 の 目的:
- 新生児性セプシスの病因学,診断,および管理に関する最新のレビューを提供するため.
- 抗生物質耐性の予防における抗生物質管理の重要性を強調する.
主な方法:
- 2025年1月に主要なデータベース (PubMed,Embase,Cochrane Library,Scopus) で包括的な文献検索が行われました.
- 対象となった研究は,メタ解析,RCT,臨床試験,および2005年から2025年にかけて英語で発表されたレビューで,新生児性セプシスに焦点を当てたものです.
主要な成果:
- 異なる病原体は,新生児の早期発症,遅発症,病院内感染に寄与する.
- 早期の認識,診断,および経験的な抗生物質は,より良い結果のために不可欠です.
- グループBのストレプトコックスのスクリーニングにより,早期発症のセプシスが減少した一方で,抗菌剤耐性は依然として課題です.
結論:
- 最適な新生児性セプシス管理には,病原体の早期発見,慎重な抗生物質の選択,そして強力な抗菌薬管理が必要です.
- 将来の研究は,エビデンスベースのプロトコル,高度な診断,およびパーソナライズされたケアに焦点を当てるべきです.
関連する概念動画
Factors Affecting Drug Response: Overview
When it comes to infants and young children, they are typically administered smaller doses of medication in comparison to adults. This is primarily because their organ functions still need to fully develop, meaning their bodies are not as efficient at metabolizing or eliminating drugs. Additionally, their blood-brain barrier is more permeable than in adults. As a result, high concentrations of drugs can easily penetrate the central nervous system (CNS), potentially leading to neurological...
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption
Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
Pharmacokinetics in Pediatric Patients: Drug Metabolism
In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses a challenge in...
Pharmacokinetics in Pediatric Patients: Drug Excretion
In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
Microorganisms in Medicine and Therapeutics
Microorganisms play a fundamental role in vaccine development, gene therapy, and therapeutic production. Their biological properties are harnessed to advance medicine and public health. Beyond immunization, microorganisms contribute to gut health, antibiotic synthesis, and genetic disease treatment.Live Attenuated and Inactivated VaccinesLive attenuated vaccines, such as the measles, mumps, and rubella (MMR) vaccine, utilize weakened forms of pathogens to closely resemble natural infections.
Microbiota Modulation by Antibiotics
Antibiotics have revolutionized modern medicine by saving countless lives from bacterial infections. However, their widespread use has inadvertently harmed the delicate balance of the human gut microbiota. The gut microbiota, a complex community of bacteria, archaea, viruses, and fungi, plays a vital role in regulating metabolism, immune responses, and maintaining intestinal health. Antibiotics, especially broad-spectrum types, disrupt this ecosystem by eradicating both harmful and beneficial...

